Accuray (ARAY) Cash & Equivalents (2010 - 2026)
Accuray's (ARAY) quarterly Cash & Equivalents came in at $38.1 million in Q1 2026, down 51.09% year-on-year from $77.8 million in Q1 2025, and down 7.82% quarter-over-quarter from $41.3 million in Q4 2025.
Accuray (ARAY) Cash & Equivalents (2010 - 2026) Analysis & Trends
Accuray's Cash & Equivalents history runs 17 years deep, the most recent figure standing at $38.1 million for Q1 2026.
- On a quarterly basis, Cash & Equivalents fell 51.09% year-over-year to $38.1 million in Q1 2026; TTM through Mar 2026 was $38.1 million, a 51.09% decrease from a year earlier, with the FY2025 full-year figure at $57.4 million, down 16.27% from the prior year.
- Cash & Equivalents declined to $38.1 million in Q1 2026 per ARAY's latest filing, from $41.3 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $89.4 million in Q2 2023 and bottomed at $189000.0 in Q4 2022.
- The 5-year median for Cash & Equivalents is $59.2 million (2024), against an average of $47.2 million.
- Across the five-year window, Cash & Equivalents sank 99.85% in 2022 and jumped 43724.51% in 2023, its largest moves.
- Year by year, Cash & Equivalents stood at $189000.0 in 2022, then surged by 38395.24% to $72.8 million in 2023, then dropped by 13.98% to $62.6 million in 2024, then plunged by 34.02% to $41.3 million in 2025, then dropped by 7.82% to $38.1 million in 2026.
- Per Business Quant, the three latest ARAY Cash & Equivalents figures stand at $38.1 million (Q1 2026), $41.3 million (Q4 2025), and $63.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.03 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 557.00 Mn |
| 10 | Accuray | 29,832.96 | -38.50 Mn | 25.29 Mn | 38.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.07 Mn |
| Dec 31, 2025 | 41.30 Mn |
| Sep 30, 2025 | 63.34 Mn |
| Jun 30, 2025 | 57.42 Mn |
| Mar 31, 2025 | 77.82 Mn |
| Dec 31, 2024 | 62.58 Mn |
| Sep 30, 2024 | 59.21 Mn |
| Jun 30, 2024 | 68.57 Mn |
| Mar 31, 2024 | 674,000.00 |
| Dec 31, 2023 | 72.76 Mn |
| Sep 30, 2023 | 524,000.00 |
| Jun 30, 2023 | 89.40 Mn |
| Mar 31, 2023 | 89.06 Mn |
| Dec 31, 2022 | 189,000.00 |
| Sep 30, 2022 | 81.01 Mn |
| Jun 30, 2022 | 204,000.00 |
| Mar 31, 2022 | 205,000.00 |
| Dec 31, 2021 | 123.20 Mn |
| Sep 30, 2021 | 553,000.00 |
| Jun 30, 2021 | 560,000.00 |